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The purpose of this paper is to investigate and develop methods
for analysis of multi-center randomized clinical trials which only rely
on the randomization process as a basis of inference. Our motivation
is prompted by the fact that most current statistical procedures used
in the analysis of randomized multi-center studies are model based.
The randomization feature of the trials is usually ignored. An impor-
tant characteristic of model based analysis is that it is straightforward
to model covariates. Nevertheless, in nearly all model based analyses,
the effects due to different centers and, in general, the design of the
clinical trials are ignored. An alternative to a model based analysis is
to have analyses guided by the design of the trial. Our development
of design based methods allows the incorporation of centers as well as
other features of the trial design. The methods make use of condition-
ing on the ancillary statistics in the sample space generated by the
randomization process. We have investigated the power of the meth-
ods and have found that, in the presence of center variation, there is
a significant increase in power. The methods have been extended to
group sequential trials with similar increases in power.
1. Introduction. The randomized multi-center clinical trial is widely rec-
ognized as the ideal way to generate data to evaluate the benefit of therapies
for the treatment of disease. The randomization process tends to eliminate
bias introduced by physicians or patient preferences. In addition to random-
ization, sometimes double blind trials are used to eliminate such bias when
the outcomes are subjective. Randomization also serves to balance unknown
factors over treatments which may affect outcome. Randomization was first
introduced by Fisher in 1935 [see Fisher (1971)] and was motivated by ex-
perimental design problems in agriculture. Randomization has proved to be
equally important in studies on humans so that today randomized clinical
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trials are regarded as part of the foundation of the scientific basis of modern
medicine.
Current practice in the analyses of randomized clinical trials is to use
statistical methods which are model based; for example, linear, logistic and
proportional hazard models. These methods are ideal for taking into ac-
count factors which influence outcome. However, the inference requires that
subjects entering a trial constitute a random sample of subjects from a well
defined population. Unfortunately this is rare. Subjects entering a trial are
not a random sample of patients. We refer to these subjects as a “collection”
of patients. Consequently, the basis of any inference is questionable in the
absence of a random sample of subjects.
The randomization process can serve as a basis of inference and is an
alternative to relying on a random sample as the basis of inference. In our
view, in the absence of a random sample of patients, model based analy-
ses are appropriate when they serve as approximations to a randomization
analysis. However, relying on the randomization process limits the scope of
the resulting inference. The inference strictly applies to the “collection” of
subjects who have entered the trial. Any generalization of the inference to
a population with disease must be made on how well the “collection” of
patients in the trial approximates a well-defined disease population.
Under a population model, model-based methods test the null hypothesis
of the equality of parameters from known distributions, while the null hy-
pothesis of a randomization-based test is that the assignment of treatments
A and B had no effect on the outcomes of the subjects enrolled in the study.
A 1988 special issue of Controlled Clinical Trials was devoted to dis-
cussing the statistical properties of randomization procedures in clinical
trials. Special topics included simple randomization [Lachin (1988)], per-
muted block randomization [Matts and Lachin (1988)] and the urn-adaptive
biased-coin randomization [Wei and Lachin (1988)]. Lachin, Matts, and Wei
(1988), in the conclusion paper of the issue, shared the same view as ours.
The main ideas in these papers have been summarized later in the book by
Rosenberger and Lachin (2002).
The aim of this paper is to investigate randomization based analyses of
randomized multi-center trials. A guiding principle in our development is
that the analysis should take into account the design of the trial. Most
randomized clinical trials are designed using permuted blocks. This feature of
a trial is usually ignored in the model driven analyses. Dividing the patients
into blocks enables balance among treatments with reference to a possible
change in the population over time and the possibility of changing benefit
over time; that is, physicians acquiring experience in the administration of
the treatment will be better able to administer the treatment.
A widely accepted principle in frequentist inference is to condition the
analysis on the ancillary statistics. Conditioning on ancillary statistics will
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reduce the sample space and generally will result in greater power compared
to ignoring the ancillary statistics. Nevertheless, most frequentist analyses
of randomized trials ignore the ancillary statistics. For example, ancillary
statistics arise most naturally in randomized multi-center clinical trials in
which the ancillary statistics are the number of patients assigned to each
treatment within a center. Although the treatment sample sizes within each
center are random variables, nearly all model-based analyses that incorpo-
rate center effects treat the sample sizes within centers as fixed quantities
and ignore the probability aspects of the sample sizes. When the sample
sizes within a center are large, this distinction may not be important. How-
ever in many multi-center trials there may be large numbers of centers which
enter a relatively small number of patients. In such situations, modeling a
parameter for each institution can result in a significant reduction in the
precision of the test statistic. An alternative to adding more parameters is
to reduce the sample space by conditioning [Pesarin (2001)]. The power of
clinical trials may be increased by conditioning on the institutional sample
sizes for each treatment. Conditioning on the sample sizes of centers is an
illustration of how a randomization-based analysis of a trial may adjust for
covariates. In this case the centers are the covariates. This idea generalizes
when there are an arbitrary number of covariates.
Many approaches have been proposed to adjust for center effect in multi-
center studies in the past. The majority of the adjustments use model-based
methods, as reviewed by Localio, Berlin, Ten Have, and Kimmel (2001). The
methods adjusting for center effects include the following: mixed-effects,
random-effects, multistage hierarchical [Skene and Wakefield (1990),
Matsuyama, Sakamoto, and Ohashi (1998)], Bayesian approach [Gray (1994),
Yamaguchi, Ohashi, and Matsuyama (2002)] and frailty models for survival
data [Andersen, Klein, and Zhang (1999)]. Boos and Brownie (1992) devel-
oped rank based methods to account for institution variation.
Davis and Chung (1995) developed a Mantel–Haenszel mean score statistic
using a randomization model for continuous or ordered categorical outcomes.
The estimator, which is a weighted average of the center-specific mean dif-
ferences, is equivalent to the estimate obtained using a fixed-effect model.
Potthoff, Peterson, and George (2001) investigated several permutation tests
for treatment-by-center interaction in multi-center clinical trials with sur-
vival outcomes. Brunner, Domhof, and Puri (2002) considered nonparamet-
ric tests where the statistics are weighted according to the different sample
sizes within the levels of one factor. In general, there is very limited literature
related to adjusting center effects using randomization-based methods.
The aim of this paper is to investigate randomization-based analyses, in
which the experimental design is a permuted block design, and covariate ad-
justments are made by conditioning on the ancillary statistics. Comparisons
are made with model-based analyses for linear, logistic and proportional
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hazard models. The conditioning on the ancillary statistics, in the presence
of permuted blocks, generates some difficult combinatorial problems. To deal
with this class of problems, we principally base our analyses on large sample
procedures.
The paper is organized as follows. Section 2 formulates the problem and
introduces notation. Section 3 presents the method for the analysis of multi-
center trials using permuted block designs. Section 4 applies the idea to
group sequential randomized clinical trials. Section 5 concludes with a dis-
cussion.
2. Problem formulation and notation. The key idea in using the random-
ization process as a basis for inference is that the only probability in a study
is the introduction of uncertainty by the random assignment of treatments
to patients. Patient outcomes are considered fixed and are not governed by
probability distributions. The statistical procedures are based only on the
randomization process and are distribution free. Conceptually, the distribu-
tion of the appropriate statistics can be obtained by enumerating the entire
sample space. However, enumeration may not be feasible with large numbers
of observations. Instead, the distribution may be approximated by sampling
the sample space or using large sample approximations based on low order
moments.
2.1. Permuted blocks. A major disadvantage of simple randomization
is the possibility of generating unbalanced numbers of patients in treat-
ments. Permuted block designs eliminate such possible imbalances. The ba-
sic idea of a permuted block design is to group patients into “blocks” ac-
cording to the time entered in the study. Randomization is then carried
out within each individual block, so that there is an equal number of sub-
jects assigned to each treatment within a block. The application of per-
muted blocks is also viewed as a protection against unknown time trends
in either the treatment effects or patient characteristics; that is, the ap-
plication of the treatments may become more efficacious as more expe-
rience is gained with the treatments. A disadvantage of permuted block
designs for single institution studies is that at certain allocations in the
trial, a treatment assignment could be known to investigators, in advance
of randomization. However, this phenomenon is unlikely in multi-center tri-
als.
2.2. Notation and permuted blocks: Single institution. Consider a single-
center randomized clinical trial comparing two treatments denoted by A and
B. Let a single permuted block contain N patients. Suppose there are P
permuted blocks. Define the binary random variable
δij =
{
1, if ith patient in jth block is assigned to A,
0, otherwise,
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where i= 1,2, . . . ,N ; j = 1,2, . . . , P . The treatments are randomly assigned,
that is, P{δij = 1}= 12 subject to
∑N
i=1 δij =
N
2
for j = 1,2, . . . , P . The dis-
tribution properties of the {δij} for the permuted blocks is well known and
easily derived. The low order moments are
E
[
δij
∣∣∣ N∑
i=1
δij =
N
2
]
=
1
2
, Var
(
δij
∣∣∣ N∑
i=1
δij =
N
2
)
=
1
4
,
Cov
(
δij , δrj
∣∣∣ N∑
i=1
δij =
N
2
)
=− 1
4(N − 1) for i 6= r.
Let yij be the observed outcome for the ith patient in the jth block re-
gardless of treatment assignment. This formulation assumes no difference
between treatments. Then SA =
∑P
j=1
∑N
i=1 δijyij and SB =
∑P
j=1
∑N
i=1(1−
δij)yij are the observed outcome totals for each treatment group. The out-
comes {yij} are assumed to be fixed quantities. Note that with this formu-
lation, SA + SB = S =
∑B
j=1
∑N
i=1 yij is a fixed quantity.
A comparison of the two groups is usually carried out by comparing the
distribution of the difference of the sample averages; that is,
D =
SA
NP/2
− SB
NP/2
=
2
NP
(2SA − S).
The inference on the treatment difference may then be made by considering
the conditional randomization distribution of D or, equivalently, of SA, since
SA is the only random variable in D. The randomization distribution of SA
can be obtained by considering the randomization distribution in each block
and taking the convolution among the blocks. For example, if N = 4, there
will be
(4
2
)
= 6 possible assignment outcomes and the number of points in
the sample space would be 6P , where P is the number of permuted blocks.
Thus, a trial with 100 subjects would have 625 = 2.8 × 1019 points in the
sample space. It would be impossible to enumerate such a large sample
space. However, the randomization distribution may be approximated by
using a normal distribution utilizing lower order moments or sampling the
sample space.
Define SjA =
∑N
i=1 δijyij and since S
j
A is a function of {δij}, we have
E
[
SjA
∣∣∣N jA = N2
]
=
1
2
Ny¯j where y¯j =
1
N
N∑
i=1
yij;
σ2j = V
(
SjA
∣∣∣N jA = N2
)
=
N
4(N − 1)
N∑
i=1
(yij − y¯j)2 for j = 1,2, . . . , P.
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Then the analysis proceeds by defining SA =
∑P
j=1S
j
A and
E
[
SA
∣∣∣N jA = N2 , j = 1,2, . . . , P
]
=
1
2
N
P∑
j=1
y¯j;
Var
(
SA
∣∣∣N jA = N2 , j = 1,2, . . . , P
)
= σ2 =
P∑
j=1
σ2j .
Since permuted blocks are independent, by the central limit theorem, as P
becomes large, (SA −E[SA|N jA = N2 , j = 1,2, . . . , P ])/σ will have an approx-
imate standard normal distribution under the hypothesis of no difference
between the two treatments; that is,
SA − 12N
P∑
j=1
y¯j
·∼N
(
0,
P∑
j=1
σ2j
)
.
3. Multi-center clinical trials.
3.1. Treatment assignment and covariates. A characterization of clinical
trials is that patients are entered in a trial in a sporadic fashion over time.
Ordinarily most clinical trials are designed so that there are approximately
equal numbers of patients for each treatment at any point in time in the
accrual phase of a trial. This is accomplished by using permuted blocks to
randomize patients over time. If there are other prognostic factors influenc-
ing the outcomes, in the absence of stratified randomization, the number
of patients on each treatment within the level of a prognostic factor would
be a random variable. Multi-center trials are the most notable example of
this phenomenon. When patients are randomized over time, the number
of patients on each treatment, within an institution, is a random variable.
Furthermore, if there are other prognostic variables, the number of patients
assigned to each treatment at each variable level will be a random variable.
Note that if the trial design uses permuted blocks over time, then one can-
not carry out randomization with an institution. Alternatively, a trial may
be designed so that the randomization process is stratified by institution.
Then permuted blocks over time cannot be implemented. If the institutions
enroll a relatively large number of patients, then it will be feasible to utilize
permuted blocks within an institution. However, most trials have a large
number of institutions which enroll a relatively small number of patients.
Consequently, it is not feasible to stratify using permuted blocks within an
institution. As noted earlier, for most clinical trials, randomization schemes
are guided by permuted blocks over time.
In general, the method of analysis to adjust for a prognostic variable is to
condition on the ancillary statistics. The resulting conditional distribution
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of the test statistic may be impossible to derive because it is necessary to
also condition on the permuted blocks. When there are two or more prog-
nostic variables, the conditioning can account for interactions between the
prognostic variables. The method of analysis will be illustrated by applying
it to account for institutional variation. It should be noted that, in practice,
the usual model-based analyses do not account for institutional variation.
3.2. Multi-center trials. In our development of multi-center trials, it will
be assumed that permuted blocks allocate patients to treatments over time.
As a result, the number of patients assigned to each treatment within an
institution will be a random variable. These are ancillary statistics and the
analysis will condition on patient treatment numbers within each institution.
We will use the following notation:
P = number of permuted blocks;
K = number of institutions;
Njk = number of patients from institution k in the jth block;
N
.k =
∑P
j=1Njk = number of patients from institution k;
njkA = number of patients assigned to A from institution k in the jth block;
nkA =
∑P
j=1 n
j
kA = number of patients assigned to A in kth institution;
yij = outcome of ith patient in jth block (i= 1,2, . . . ,N );
δij = 1 if ith patient in jth block is assigned to A; 0 otherwise.
It will be convenient to set Yj = (y1j , y2j, . . . , yNj)
′.
In considering the randomization distribution, the quantities {Njk} are
assumed to be fixed. Without conditioning, enumerating all possible treat-
ment assignments within blocks will result in different {njkA} and {nkA}
values as the block assignments are independent of institutions. The num-
ber of points in the sample space is
S({njkA}) =
∑
S∗
P∏
j=1
K∏
k=1
(
Njk
njkA
)
,
where we define
(m
n
)
= 1 if either m or n is 0 and the summation is over the
set S∗ = {∑Kk=1 njkA = N2 , j = 1,2, . . . , P}.
If we condition on {nkA}, enumerating the treatment assignments will be
restricted to keeping {nkA} as constants, that is, {njkA} can result in differ-
ent numerical values depending on treatment assignment, but is restricted
to values that satisfy
∑P
j=1n
j
kA = nkA = constant, for k = 1,2, . . . ,K. The
conditional sample space has fewer points and is explicitly
T ({njkA}) =
∑
T ∗
P∏
j=1
K∏
k=1
(
Njk
njkA
)
,
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where T ∗ = {∑Kk=1njkA = N2 , j = 1, . . . , P ;∑Pj=1 njkA = nkA, k = 1, . . . ,K}.
Consequently, the conditional distribution of the {njkA} is T ({njkA})/S({njkA}).
With K more restrictions on the possible assignments across the blocks, the
{njkA} are no longer independent of the blocks. As a result, the mean and
variance of the test statistic are difficult to calculate. Furthermore, resam-
pling from the set T is not readily carried out, so that resampling cannot
be used to approximate the distribution.
In order to approximate the conditional distribution of SA, as defined in
Section 2.2, based on low order moments, we will consider the randomiza-
tion process as being generated by a permuted block design. The following
notation is needed. Define
Iijk =
{
1, if ith patient in jth block is from institution k,
0, otherwise.
For each patient within a block, define aK×1 vector Iij = (Iij1, Iij2, . . . , IijK)′,
i= 1, . . . ,N ; j = 1, . . . , P . Consequently, for each block, there exists a N×K
matrix Ij = (I
′
1j , I
′
2j, . . . , I
′
Nj)
′, j = 1,2, . . . , P . The basic relations among the
{Iijk} are
K∑
k=1
Iijk = 1;
N∑
i=1
Iijk =Njk;
P∑
j=1
N∑
i=1
Iijk =N.k;
N∑
i=1
δijIijk = n
j
kA;
K∑
k=1
N∑
i=1
δijIijk =
N
2
;
P∑
j=1
N∑
i=1
δijIijk = nkA.
3.3. Approximation using multivariate normal distribution. In this sec-
tion we will extend the results for permuted block designs developed in Sec-
tion 2.2 to multi-center trials. Consider njkA =
∑N
i=1 δijIijk (k = 1,2, . . . ,K)
and SjA =
∑N
i=1 δijyij. The joint distribution of S
j
A and {njkA} will be ap-
proximately multivariate normal. We can then obtain the distribution of SA
conditional on {nkA}.
Note that SA and {nkA} are linear functions of {δij}; that is,
SA =
P∑
j=1
SjA =
P∑
j=1
N∑
i=1
δijyij;
nkA =
P∑
j=1
njkA =
P∑
j=1
N∑
i=1
δijIijk, k = 1, . . . ,K.
Then by extending the results in Section 2.2, we have the conditional
mean and variance of SjA and {njkA} for any block j; that is,
E
[
SjA
∣∣∣N jA = N2
]
=
1
2
N∑
i=1
yij and
RANDOMIZATION AND ANCILLARY STATISTICS 9
Var
(
SjA
∣∣∣N jA = N2
)
=
1
4
N
N − 1
N∑
i=1
(yij − y¯j)2,
E
[
n
j
A
∣∣∣N jA = N2
]
=
1
2
Nj. and
Var
(
n
j
A
∣∣∣N jA = N2
)
=
1
4
N
N − 1
(
Diag(Nj.)−
Nj.N
′
j.
N
)
,
Cov
(
SjA, n
j
kA
∣∣∣N jA = N2
)
=
1
4
N
N − 1Y
′
j
(
I− J
N
)
Ijk, k = 1,2, . . . ,K,
where njA = (n
j
1A, n
j
2A, . . . , n
j
KA)
′ and Nj. = (Nj1,Nj2, . . . ,NjK)
′ and Ijk =
(I1jk, I2jk, . . . , INjk)
′ is the kth column in Ij.
Since the permuted blocks are independent, by the multivariate central
limit theorem, SA and {nkA} will have an approximate (K+1)-multivariate
normal distribution, that is,
1√
P


(
SA
n
.A
)
−1
2


P∑
j=1
N∑
i=1
yij
N
..



 ·∼N
(
0,
∑P
j=1 Vj
P
)
,
where n
.A = (n1A, n2A, . . . , nKA)
′,N
..
= (N
.1,N.2, . . . ,N.K)
′ and
Vj =


Var
(
SjA
∣∣∣N jA = N2
)
Cov
(
SjA,n
j
A
∣∣∣N jA = N2
)′
Cov
(
SjA,n
j
A
∣∣∣N jA = N2
)
Var
(
n
j
A
∣∣∣N jA = N2
)

 .
Consequently, the conditional distribution of SA|n.A will be approxi-
mately normal with mean and variance given by standard multivariate nor-
mal theory; for example,
E[SA|{nkA}] = 1
2
P∑
j=1
N∑
i=1
yij +
{
P∑
j=1
Cov
(
SjA,n
j
A
∣∣∣N jA = N2
)′}
×
{
P∑
j=1
Var
(
n
j
A
∣∣∣N jA = N2
)}−
·
(
n
.A − 1
2
N
..
)
;
Var(SA|{nkA}) =
P∑
j=1
Var
(
SjA
∣∣∣N jA = N2
)
−
{
P∑
j=1
Cov
(
SjA,n
j
A
∣∣∣N jA = N2
)′}
×
{
P∑
j=1
Var
(
n
j
A
∣∣∣N jA = N2
)}−
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×
{
P∑
j=1
Cov
(
SjA,n
j
A
∣∣∣N jA = N2
)}
,
where (·)− is a generalized inverse.
See Harville (1997) for more theory and application of the generalized
inverse. A generalized inverse of a matrix can be obtained using most stan-
dard statistical software. In the simulation studies (Section 3.4), the R
[R Development Core Team (2007)] function ginv in package MASS was
used to generate the Moore–Penrose generalized inverse.
3.4. Simulation studies. Simulation studies are carried out to character-
ize the behavior of the conditional test for continuous, binary and censored
outcomes. The simulations also explore the effect of block size and number
of institutions. Block sizes are chosen to be 4, 6 and 8. The number of in-
stitutions varies from 10 to 140 depending on sample sizes (120, 240 and
360). For each sample size, the average number of patients per institution
ranges from 3 to 20. The size of the treatment effect is chosen such that
the power of the tests is at meaningful levels for comparison purposes. Con-
tinuous outcomes are drawn from a lognormal distribution with treatment
difference of 1.07. Institution effects are drawn from a normal distribution
with a standard deviation of 2. For binary outcomes, the underlying dis-
tribution is Bernoulli with success probabilities 0.5 and 0.7, respectively. A
logistic model is used for the treatment and institution effects [drawn from
a N(0, 1.73)]. In the case of censored outcomes, the survival times are gener-
ated from exponential distributions with a ratio of 1.5 for the two treatment
mean survival times. Institution effects are introduced using a multiplicative
model and are drawn from a χ2 distribution with 1 df.
When the outcomes are right-censored time-to-event data with nonin-
formative censoring, the outcome variable yij is replaced with specific test
statistics calculated within each block and then aggregated over the blocks.
In practice, the logrank score or Gehan score is used to test the null hypoth-
esis that there is no difference in the survival of the individuals in the two
groups. To test the null hypothesis that the mortality rate is the same for the
two groups, mortality rates are calculated and used in place of y¯j . We used
both logrank and Gehan scores in the simulation studies. The simulations
were set up so that each group had the same censoring rate.
For all three types of outcomes, the power of the conditional test was com-
pared with commonly used tests ignoring institutions. Comparisons were
made both ignoring blocks and stratifying by blocks. For continuous out-
comes, the conditional test was compared with the two-sample t test based
on the treatment contrast within each block, which we denote as a “stratified
t test” in the tables. Also, comparisons were made for a two-sample t test,
RANDOMIZATION AND ANCILLARY STATISTICS 11
Table 1
Power comparison for continuous outcomes with no block variation
Sample size No.
of institutions
120 240 360
10 20 40 20 40 60 80 20 40 60 80 100
Block size 4
Conditional test 0.53 0.47 0.35 0.81 0.76 0.69 0.62 0.93 0.92 0.90 0.85 0.82
Randomization test 0.42 0.40 0.39 0.68 0.70 0.67 0.67 0.85 0.84 0.84 0.83 0.85
Stratified t 0.43 0.40 0.40 0.68 0.68 0.67 0.67 0.85 0.84 0.84 0.83 0.85
t-test 0.43 0.40 0.40 0.68 0.68 0.67 0.67 0.85 0.84 0.84 0.83 0.85
Block size 8
Conditional test 0.53 0.48 0.39 0.81 0.76 0.72 0.65 0.94 0.93 0.91 0.89 0.85
Randomization test 0.42 0.40 0.39 0.69 0.67 0.68 0.66 0.85 0.84 0.84 0.84 0.84
Stratified t 0.42 0.40 0.39 0.69 0.67 0.68 0.66 0.85 0.84 0.84 0.84 0.84
t-test 0.42 0.40 0.40 0.69 0.67 0.68 0.67 0.85 0.84 0.84 0.84 0.84
Note. Data are generated from a lognormal distribution. The difference between the two
group means is 1.07.
which ignores both institutions and blocks. In the case of binary outcomes,
the conditional test was compared with both the Mantel–Haenszel test of P
2× 2 tables with each block forming a 2× 2 table and a simple 2× 2 table
which pooled all the data. For censored outcomes, the reference tests are
the block stratified Gehan and logrank tests and the logrank test ignoring
blocks and institutions. Those reference tests are chosen because, in prac-
tice, they are most likely to be employed in the analyses of clinical trials
using permuted blocks or ignoring the permuted blocks. Also included in
the comparisons was the test based on the randomization distribution gen-
erated by permuted blocks, ignoring the conditioning on institutions. The
latter test is denoted as “the randomization test” in the tables. Type I error
rates were examined where there is no treatment difference. The simulations
(results not presented here) showed that all tests had the correct type I error
rates at levels 0.01 and 0.05. All censoring was noninformative for censored
outcomes.
Tables 1–4 show selected results from the simulations. Each table entry
is based on the average of 5000 replications. All tests are two-sided with
0.05 type I error rate. Note that the conditional tests have higher power
than their counterparts for each of the three types of outcomes for nearly
all institution sizes when institution variation is present. The power of the
conditional test decreases as the number of institutions increases for a fixed
sample size. This is in contrast to the power of the reference tests which
decrease slightly or remain the same for a fixed sample size. Keeping the
total sample size fixed, but allowing the number of institutions to increase,
results in decreasing the average sample sizes within an institution. Also,
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there are more opportunities for treatment assignment imbalances as the
number of institutions increases. Treatment imbalances result in decreased
statistical efficiency. The imbalances are particularly acute with small in-
stitution sample size. For example, an entry of one patient or two patients
assigned to the same treatment within an institution carry no information
for comparing two treatments.
Tables 1 and 2 show simulation results for continuous outcomes with and
without block effects. A block effect is added to the outcomes (−1, −0.5, 0.5
Table 2
Power comparison for continuous outcomes with block variation
Sample size No.
of institutions
120 240 360
10 20 40 20 40 60 80 20 40 60 80 100
Block size 4
Conditional test 0.52 0.47 0.34 0.81 0.75 0.69 0.59 0.93 0.92 0.89 0.86 0.81
Randomization test 0.42 0.40 0.38 0.70 0.67 0.68 0.67 0.85 0.84 0.84 0.84 0.83
Stratified t 0.42 0.41 0.38 0.70 0.67 0.69 0.67 0.85 0.84 0.84 0.84 0.83
t-test 0.39 0.38 0.37 0.68 0.65 0.67 0.65 0.84 0.83 0.83 0.82 0.82
Block size 8
Conditional test 0.54 0.48 0.38 0.82 0.77 0.72 0.64 0.94 0.92 0.90 0.88 0.84
Randomization test 0.41 0.40 0.40 0.69 0.69 0.67 0.67 0.84 0.84 0.84 0.84 0.84
Stratified t 0.42 0.40 0.40 0.69 0.69 0.67 0.68 0.84 0.84 0.84 0.84 0.84
t-test 0.39 0.37 0.37 0.67 0.67 0.66 0.65 0.83 0.83 0.82 0.83 0.82
Note. Data are generated from a lognormal distribution. The difference between the two
group means is 1.07.
Table 3
Power comparison for binary outcomes
Sample size No.
of institutions
120 240 360
10 20 40 20 40 60 80 20 40 60 80 100
Block size 4
Conditional test 0.37 0.32 0.25 0.64 0.58 0.52 0.46 0.82 0.79 0.76 0.72 0.67
Mantel–Haenszel & RTa 0.30 0.27 0.27 0.48 0.47 0.49 0.49 0.65 0.65 0.65 0.65 0.65
Single 2× 2 table 0.30 0.28 0.28 0.49 0.48 0.50 0.50 0.66 0.65 0.66 0.65 0.65
Block size 8
Conditional test 0.45 0.41 0.32 0.72 0.68 0.63 0.58 0.89 0.87 0.84 0.82 0.79
Mantel–Haenszel & RT 0.39 0.38 0.37 0.63 0.62 0.62 0.63 0.80 0.80 0.79 0.80 0.81
Single 2× 2 table 0.40 0.39 0.38 0.64 0.63 0.64 0.65 0.80 0.80 0.80 0.80 0.81
Note. Data are generated from the Bernoulli distribution. Success probabilities for two
treatments are 0.5 and 0.7 respectively.
aRT refers to the randomization test ignoring institutions.
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and 1 each for one quarter of the blocks) to reflect a trend. With block effects,
the superiority of the conditional test tends to be greater compared to the
t-test. The randomization test and the stratified t-test also outperform the
t-test as their performances are not affected by the block variation. Also, it
is more noticeable that, with block variation, the power of the conditional
tests is slightly higher with larger block sizes.
4. Conditional group sequential tests based on randomization. Jennison
and Turnbull (1997) have extended group sequential analysis to incorporate
covariates in a wide range of generalized linear models and the proportional
hazards model for survival data. However, to our knowledge, there is no
method developed for group sequential analysis using randomization based
tests which also adjusts for covariates.
We illustrate the details of the conditional group sequential test for con-
tinuous outcomes. Procedures for censored outcomes and proportions are
similar. Suppose we intend to monitor the data to a maximum of L interim
analyses. At the lth interim analysis, let Pl refer to the cumulative number
of permuted blocks utilized up to this time. Hence, the number of patients
at the lth interim analysis will be NPl, where N is the block size. Let the in-
formation fraction tl = Pl/Pmax, where PL = Pmax. The test statistic SA(tl)
Table 4
Power comparison for censored outcomes
Sample size No.
of institutions
120 240 360
10 20 40 20 40 60 80 20 40 60 80 100
Block size 4
CT (Gehan score)a 0.23 0.19 0.14 0.39 0.34 0.29 0.25 0.55 0.50 0.46 0.41 0.39
Stratified Gehan 0.16 0.14 0.12 0.24 0.23 0.21 0.22 0.34 0.31 0.30 0.29 0.29
CT (Logrank score)a 0.23 0.18 0.14 0.38 0.34 0.27 0.25 0.54 0.49 0.44 0.40 0.38
RT (Logrank score)a 0.16 0.15 0.13 0.25 0.23 0.21 0.22 0.36 0.32 0.31 0.30 0.30
Stratified Logrank 0.16 0.15 0.13 0.25 0.23 0.21 0.22 0.36 0.33 0.31 0.30 0.31
Logrank test 0.21 0.19 0.18 0.33 0.31 0.30 0.30 0.46 0.43 0.42 0.42 0.41
Block size 8
CT (Gehan score)a 0.27 0.25 0.20 0.47 0.41 0.37 0.33 0.64 0.59 0.56 0.53 0.49
Stratified Gehan 0.17 0.16 0.14 0.26 0.24 0.22 0.22 0.36 0.34 0.32 0.33 0.32
CT (Logrank score)a 0.27 0.24 0.19 0.45 0.39 0.35 0.31 0.62 0.57 0.53 0.51 0.47
RT (Logrank score)a 0.18 0.16 0.16 0.27 0.25 0.25 0.24 0.39 0.36 0.34 0.35 0.36
Stratified Logrank 0.18 0.16 0.16 0.27 0.26 0.25 0.24 0.39 0.36 0.35 0.35 0.36
Logrank test 0.21 0.19 0.18 0.31 0.31 0.30 0.29 0.45 0.43 0.41 0.42 0.42
Note. Data are generated from an exponential distribution. Ratio of two mean survival
times is 1.5. Percentage of censored observations is 19%.
aCT refers to the conditional test using the Gehan or the logrank score; RT refers to the
randomization test ignoring institutions using the logrank score.
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is the sum of the inner product of the {δij} and outcomes {yij} in each block
up to the Plth block, that is,
SA(tl) =
Pl∑
j=1
SjA =
Pl∑
j=1
N∑
i=1
δijyij.
Conditional on n
.A(tl) = (n1A(tl), n2A(tl), . . . , nKA(tl))
′, where nkA(tl) is the
number of patients assigned to treatment A in the kth institution up to the
time before the lth interim analysis, SA(tl) is approximately normal with
mean and variance given in Section 3.3.
The test statistic T (tl) at each interim analysis is computed as
T (tl) =
SA(tl)−E[SA(tl)|n.A(tl)]√
Var(SA(tl)|n.A(tl))
and compared to a pre-specified boundary Cl, l = 1,2, . . . ,L. The null hy-
pothesis of no difference in treatments is rejected if |T (tl)| > Cl for some
l= 1, . . . ,L.
We carried out simulations comparing conditional group sequential tests
and their counterparts for continuous, binary and censored outcomes. The
simulation setting was chosen to be the same for all types of outcomes.
The test was one-sided with significance level 0.025. Equal numbers of pa-
tients (240) coming from a number of institutions (ranging from 10 to 60)
are assigned to the two treatments using a permuted block design (Block
sizes: 4, 6 and 8). Treatment differences and institution effects followed the
same data generating scheme as in section 3.4. For continuous outcome,
the institution effects were drawn from a N(0, 2) and for binary outcome,
a logistic model was used and institution effects were drawn from a N(0,
1.73). For censored outcomes, institution effects were drawn from a scaled
χ2 distribution with 4 df. Block effects were not implemented in the sim-
ulation. Four interim analyses (L = 4) were made where the increment of
information changed by 1
4
. Stopping boundaries were calculated using the
commonly used O’Brien–Fleming rule [O’Brien and Fleming (1979)], which
is a special case of the α spending approach [Lan and DeMets (1983)]. The
O’Brien–Fleming boundary gives Cl = 2.024(4/l)
1/2 for l= 1,2,3 and 4. In
our simulations we first checked the type I error rate and found that the
observed size of the test was satisfactory close to the nominal level. Table 4
summarizes a comparison of the conditional group sequential tests verses
the usual group sequential tests (unconditional) for block sizes of N = 4
and 8 for continuous, binary and censored outcomes. For all three types of
outcomes, the conditional tests have higher power than the unconditioned
tests; cf. Table 5.
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5. Discussion. In this paper we investigated methods of analysis which
are guided by the design of the study. More specifically, the analysis is based
on the randomization process generated by permuted blocks that are used
to allocate treatments to patients over time. Another feature of this paper
is to take account of the effects associated with hospitals/treatment centers.
Institutional variation abounds in nearly all clinical trials. The more se-
vere/common the side effects, the greater the reliance on patient manage-
ment in a center. Discontinuation of treatment due to not managing the
side effects properly will result in different institutional outcomes in any
intent to treat analysis. Since many trials may be carried out with both
community hospitals and major treatment centers, there is substantial vari-
ation among hospitals with regard to patient management. Trials involv-
ing surgery, as an adjunct treatment, show institution preference for dif-
ferent surgical procedures. Patient recruitment is also an important fac-
tor leading to institutional differences among populations. In some institu-
tions, patients with co-morbid disease are not approached to enter a trial
despite being eligible. The reporting of patient refusals to participate in
a clinical trial is not usually done in a published paper. However, there
are large variations in the declination rate among institutions, which re-
flect on the different populations being entered on a trial. Closely related
is the proportion of eligible patients actually entered in a trial. Intensive
safety monitoring generally leads to more favorable outcomes. Such moni-
toring greatly varies within centers. There may be important institutional
differences in the use of ancillary nontrial treatments. For example, trials
of aspirin and heparin in patients with acute ischaemic stroke often receive
Table 5
Power comparison in the presence of institutional variation for group sequential tests:
conditional group sequential tests vs. standard tests (group sequential tests without
conditioning)
Block size 4 Block size 8
No. of institutions No. of institutions
Outcomes Type of test 10 20 40 60 10 20 40 60
Continuous Conditional 0.72 0.70 0.69 0.67 0.72 0.73 0.70 0.68
Unconditional 0.51 0.49 0.48 0.47 0.52 0.50 0.46 0.48
Binary Conditional 0.91 0.91 0.90 0.88 0.95 0.96 0.95 0.94
Unconditional 0.76 0.76 0.77 0.77 0.89 0.89 0.89 0.90
Censoreda Conditional (Logrank score) 0.64 0.63 0.62 0.56 0.86 0.83 0.83 0.80
Stratified Logrank 0.57 0.57 0.57 0.57 0.78 0.77 0.75 0.75
Note. Sample size is 480 with 4 looks at equal information increments. One-sided test
with α= 0.025.
aPercentage of censored outcomes is 18.5%.
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nontrial treatments such as glycerol and steroids. The European Carotid
Surgery Trial on endarterectomy for symptomatic carotid stenosis showed
substantial differences in the speed with which patients were entered in
the trial based on the last symptomatic event. It ranged from weeks to
months depending on institutions. Benefit from endarterectomy depended
significantly on delay to surgery after the presenting event [Rothwell et al.
(2004)]. Cancer chemotherapy trials are carried out among major cancer
centers as well as community hospitals. The differences among centers with
regard to patient management are large—especially in the management of
side effects. As clinical trials become more global, there may be substan-
tial differences within a country on methods of diagnosis and treatment,
probably resulting in even more variation among centers. The effects of
the centers may be ameliorated by conditioning on the ancillary statistics
which are the treatment sample sizes within each institution. In practice,
the institution variation can be substantial. For example, the trial used
as an illustration by Skene and Wakefield (1990) showed that the varia-
tion of placebo response rates was of the same magnitute as the variation
of the treatment effect. In another example, Yamaguchi and Ohashi (1999)
reported a much larger center variation for the baseline risk than the vari-
ation of the treatment effects in a multi-center clinical bladder cancer trial.
Andersen, Klein, and Zhang (1999) showed that if center effect is ignored,
the estimator of the main treatment effect may be quite biased and is in-
consistent.
We have shown that the design based analysis, in the presence of insti-
tution variation, results in greater power for commonly used clinical trial
designs, compared to model based analyses in which institutions, permuted
blocks and the randomization process are ignored. This is true for binary,
continuous and censored outcomes. Also, this advantage holds for group
sequential trials.
The novel idea of conditioning on the ancillary statistics provides an alter-
native method to adjust for covariates in a randomization based inference.
Conditioning on the sample sizes of institutions is an illustration of how a
randomization based analysis of a trial may adjust for covariates. In this case
the centers are the covariates and the sample size of each center is an ancil-
lary statistic. For an arbitrary covariate, the number of patients assigned to
one treatment for each level of the covariate is an ancillary statistic. Condi-
tioning on the ancillary statistics in a randomization based analysis is a way
of adjusting for the covariate effect. This idea generalizes when there are an
arbitrary number of covariates. Discretized continuous covariates can also
be adjusted using the same idea. Another approach to adjust for the contin-
uous covariates is to employ a regression model and use the residuals from
the model as responses in the proposed methods. Details of this approach
will be discussed in a follow-up paper.
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The conditional test is based on the randomization distribution generated
by the random assignment of treatments to patients. It does not make any
assumptions about sampling from a target population. Thus, inference based
on the randomization distribution is applicable to patients who entered the
study. Alternatively, model based analyses assume that patients are random
samples drawn from a population and that centers are also randomly drawn
from a population of centers. This assumption is rarely true. In fact, patients
are recruited into a study from a nonrandom selection of centers. Centers are
often chosen because of their affiliations, locations and/or expertise. Within
each center, patients are recruited because they are eligible and willing to
participate in randomized clinical trials. Thus, neither the centers nor the
patients are random samples. This raises the issue of whether the assump-
tions of the model based analysis are correct. Lachin (1988) concluded that
using model based analysis on a randomized clinical trial “becomes a mat-
ter of faith that is based upon assumptions that are inherently untestable.”
Ludbrook and Dudley (1998) surveyed 252 comparative studies published
in 5 biomedical journals and concluded that randomization tests are su-
perior to t and F tests in biomedical research where randomization is the
norm rather than random sampling from patient and institution popula-
tions.
One of the reviewers has asked about whether randomization techniques
can be used for estimation in the context of particular models. Confidence
intervals can be obtained by inverting the test. Garthwaite (1996) used
simulation in conjunction with a Robbins–Monro search process to locate
the two ends of the confidence interval by inverting randomization tests.
For censored observation, confidence intervals from the inversion of normal
tests are described in Kalbfleisch and Prentice (2002). Alternatively, one
can also obtain confidence intervals by simulation. For example, if the ratio
of two mortalities is the parameter of interest, let pˆ be the observed ratio
of mortalities (m1/m2, where m = total number of deaths/total follow-
up time). Order the survival times from the smallest to the largest. At
each time when there is a death, assign the observation to treatment 1
with probability pˆ ∗ n1/(pˆ ∗ n1 + n2), where ni is the number of people
at risk for treatment i. At each censored time, assign the observation to
treatment 1 with probability n1/(n1 + n2). The ratio of mortalities can
be calculated for each realization. One can approximate the distribution
of the ratio of mortalities by repeating the rerandomization a large num-
ber of times. The 2.5th and 97.5th percentile values of the distribution
are the 95% confidence limits for the ratio of two mortalities. Initial nu-
meric studies have shown correct coverage probabilities of the confidence
intervals under various settings including the null and alternative hypoth-
esis, when the true mortality ratio is less than 2. We have found that
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the coverage probabilities may tend to be less than 0.95 as the true ra-
tio of mortalities tend to be greater than 2. In practice, a mortality ra-
tio of 2 or greater is unlikely to be encountered in a trial. Such a su-
periority is likely to be shown in pilot and preliminary studies. It may
be unethical to evaluate such a large outcome discrepency in a clinical
trial.
In conclusion, we advocate that analyses of randomized multi-center clin-
ical trials should be guided by the design of the trial and rely on the ran-
domization process for making the inference. The methods discussed in this
paper only rely on the randomization process. Consequently, they are dis-
tribution free and are capable of accounting for institutional variation and
time trends in patient populations. In practice, the methods discussed in this
paper may lead to greater power than the conventional analysis, when there
are institution and time trends (block effects). When there is an absence
of institution and/or block effects, the power of the conditional test will be
lower than statistical tests which ignore these effects. This possibility may
be regarded as the “insurance” one must pay in accounting for potential
institution and block effects.
The conditional tests discussed here may be generalized to deal with
more complex situations. The generalizations can incorporate more than
two treatments, stratified permuted block designs, the post-hoc modeling
of covariates and missing observations. In a follow-up paper we intend to
discuss these topics.
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